Testosterone replacement treatment options for HIV-infected men

被引:26
作者
Cofrancesco, J [1 ]
Whalen, JJ [1 ]
Dobs, AS [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA
关键词
HIV infection; AIDS; testosterone; androgens; hypogonadism; sex hormones; cachexia; weight loss; wasting; anabolic steroids;
D O I
10.1097/00042560-199712010-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hypogonadism is well documented in HIV-infected men, particularly as they progress to AIDS and in those with symptoms of wasting. Testosterone deficiency can be diagnosed with simple laboratory tests, and various treatment options exist. The benefits of androgen replacement are well documented from a large body of literature and experience with hypogonadal men without HIV infection. Hypogonadal men who are given testosterone replacement have improved sexual thoughts and functioning, more energy, and improved mood. Generally, quality of life improves with such therapy. Testosterone replacement tends to maintain or improve lean body mass. The benefit, dose, and timing of testosterone replacement treatment for men with HIV infection, however, are less clear and require further study. Appropriate history and a high degree of clinical suspicion, coupled with relatively simple laboratory measurements, can confirm the diagnosis of hypogonadism in men with HIV. Various options for testosterone replacement, including injections of testosterone esters and the use of transcutaneous patches, are discussed, as are the uses of pharmacologic doses of testosterone, primarily for its potential anabolic effect.
引用
收藏
页码:254 / 265
页数:12
相关论文
共 124 条
  • [1] *ALZA CORP, 1994, TEST TEST TRANSD SYS
  • [2] Ammus S S, 1989, Adv Intern Med, V34, P191
  • [3] THE EFFECTS OF EXOGENOUS TESTOSTERONE ON SEXUALITY AND MOOD OF NORMAL MEN
    ANDERSON, RA
    BANCROFT, J
    WU, FCW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06) : 1503 - 1507
  • [4] EFFECTS OF ENDOGENOUS TESTOSTERONE AND ESTRADIOL ON SEXUAL-BEHAVIOR IN NORMAL YOUNG MEN
    BAGATELL, CJ
    HEIMAN, JR
    RIVIER, JE
    BREMNER, WJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03) : 711 - 716
  • [5] Drug therapy - Androgens in men - Uses and abuses
    Bagatell, CJ
    Bremner, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 707 - 714
  • [6] ANDROGENS - RISKS AND BENEFITS
    BARDIN, CW
    SWERDLOFF, RS
    SANTEN, RJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (01) : 4 - 7
  • [7] DRONABINOL AS A TREATMENT FOR ANOREXIA ASSOCIATED WITH WEIGHT-LOSS IN PATIENTS WITH AIDS
    BEAL, JE
    OLSON, R
    LAUBENSTEIN, L
    MORALES, JO
    BELLMAN, P
    YANGCO, B
    LEFKOWITZ, L
    PLASSE, TF
    SHEPARD, KV
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) : 89 - 97
  • [8] BEHRE HM, 1994, CLIN ENDOCRINOL, V40, P341
  • [9] TESTOSTERONE BUCICLATE (20 AET-1) IN HYPOGONADAL MEN - PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NEW LONG-ACTING ANDROGEN ESTER
    BEHRE, HM
    NIESCHLAG, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (05) : 1204 - 1210
  • [10] Oxandrolone in AIDS-wasting myopathy
    Berger, JR
    Pall, L
    Hall, CD
    Simpson, DM
    Berry, PS
    Dudley, R
    [J]. AIDS, 1996, 10 (14) : 1657 - 1662